Randrup Hansen, Caroline <br/><br/>
Effects and Side Effects of Using Sorafenib and Sunitinib in the Treatment of Metastatic Renal Cell Carcinoma.  [electronic resource] 

 -  International journal of molecular sciences  Feb 2017 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1422-0067 
<br/><br/><label>Standard No.: </label>10.3390/ijms18020461  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiogenesis Inhibitors--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Carcinoma, Renal Cell--drug therapy<br/>Disease Management<br/>Drug Resistance, Neoplasm<br/>Humans<br/>Indoles--administration & dosage<br/>Molecular Targeted Therapy<br/>Neoplasm Metastasis<br/>Neoplasm Staging<br/>Niacinamide--administration & dosage<br/>Phenylurea Compounds--administration & dosage<br/>Protein Kinase Inhibitors--administration & dosage<br/>Pyrroles--administration & dosage<br/>Sorafenib<br/>Sunitinib<br/>Treatment Outcome